Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species

BMC Microbiology

Volumn 15, Issue 1, 2015, Pages

  Silbereisen, Angelika ^a,b   Tamborrini, Marco ^a,b   Wittwer, Matthias ^c   Schürch, Nadia ^c   Pluschke, Gerd ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c SPIEZ LABORATORY   (Switzerland)

Author keywords

Antigen capture assay; Brucellosis; Luminex; Monoclonal antibodies; Multiplex

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FORMALDEHYDE; MONOCLONAL ANTIBODY; O ANTIGEN; BACTERIUM ANTIBODY; BIOLOGICAL WARFARE AGENT; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BACILLUS ANTHRACIS; BACTERIAL CELL; BACTERIUM DETECTION; BIOLOGICAL WARFARE; BRUCELLA; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCISELLA TULARENSIS; GAMMA IRRADIATION; HEATING; HYBRIDOMA; IMMUNOASSAY; LIMIT OF DETECTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; SPECIES IDENTIFICATION; YERSINIA PESTIS; ANIMAL; BIOLOGICAL WARFARE AGENT; BRUCELLOSIS; CHEMISTRY; DIAGNOSTIC TEST; EVALUATION STUDY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; TIME FACTOR;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BIOLOGICAL WARFARE AGENTS; BRUCELLA; BRUCELLOSIS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; IMMUNOASSAY; LIPOPOLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84946478444     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-015-0534-1     Document Type: Article

References (50)

1. Centers for Disease Control and Prevention. Emergency Preparedness and Response. Specific Hazards. Bioterrorism. http://www.bt.cdc.gov/bioterrorism. Accessed 9 Sept 2013.
2. Atluri VL, Xavier MN, de Jong MF, den Hartigh AB, Tsolis RM. Interactions of the human pathogenic Brucella species with their hosts. Annu Rev Microbiol. 2011;65:523-41.
3. Whatmore AM. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect Genet Evol. 2009;9:1168-84.
4. Corbel MJ. Brucellosis in humans and animals. WHO. 2006. http://www.who.int/csr/resources/publications/Brucellosis.pdf. Accessed 4 Sept 2013.
5. Cardoso PG, Macedo GC, Azevedo V, Oliveira SC. Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb Cell Fact. 2006;5:13.
6. Kubler-Kielb J, Vinogradov E. Reinvestigation of the structure of Brucella O-antigens. Carbohydr Res. 2013;378:144-7.
7. Cloeckaert A, Jacques I, de Wergifosse P, Dubray G, Limet JN. Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides. Infect Immun. 1992;60:312-5.
8. Limet J, Plommet A-M, Dubray G, Plommet M. Immunity conferred upon mice by anti-LPS monoclonal antibodies in murine Brucellosis. Annales de l'Institut Pasteur / Immunologie. 1987;138:417-24.
9. Limet JN, Bosseray N, Garin-Bastuji B, Dubray G, Plommet M. Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella. J Med Microbiol. 1989;30:37-43.
10. Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36 Suppl 1:S12-7.
11. Beninati C, Garibaldi M, Lo Passo C, Mancuso G, Papasergi S, Garufi G, et al. Immunogenic mimics of Brucella lipopolysaccharide epitopes. Peptides. 2009;30:1936-9.
12. Diaz-Aparicio E, Marin C, Alonso-Urmeneta B, Aragon V, Perez-Ortiz S, Pardo M, et al. Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol. 1994;32:1159-65.
13. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7:775-86.
14. Lucero NE, Foglia L, Ayala SM, Gall D, Nielsen K. Competitive enzyme immunoassay for diagnosis of human brucellosis. J Clin Microbiol. 1999;37:3245-8.
15. Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov. 2013;8:34-41.
16. Poester FP, Nielsen K, Samartino LE, Yu WL. Diagnosis of brucellosis. Open Veterinary Science Journal. 2010;4:46-60.
17. Wenger A, Mauer V, Dunn M. International Biodefense Handbook. An Inventory of National and International Biodefense Practices and Policies. Center for Security Studies. 2007. http://www.isn.ethz.ch/Digital-Ubrary/Publications/Detail/?ots591=0c54e3b3-1e9c-be1e-2c24-a6a8c7060233&lng=en&id=31146. Accessed 2 April 2014.
18. Baker HN, Murphy R, Lopez E, Garcia C. Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method. J Vis Exp. 2012. doi: 10.3791/4084.
19. Tamborrini M, Holzer M, Seeberger PH, Schurch N, Pluschke G. Anthrax spore detection by a luminex assay based on monoclonal antibodies that recognize anthrose-containing oligosaccharides. Clin Vaccine Immunol. 2010;17:1446-51.
20. Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, et al. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy. J Clin Microbiol. 2007;45:2923-8.
21. Pluschke G, Joss A, Marfurt J, Daubenberger C, Kashala O, Zwickl M, et al. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments. J Immunol Methods. 1998;215:27-37.
22. HyTest. Turku, Finland. 2003. http://www.hytest.fi/product/yersinia-pestis-f1-antigen-antibody. Accessed 8 Oct 2013.
23. HyTest. Turku, Finland. 2003. http://www.hytest.fi/product/francisella-tularensis-lps-antibody. Accessed 8 Oct 2013.
24. Zygmunt MS, Jacques I, Bernardet N, Cloeckaert A. Lipopolysaccharide heterogeneity in the atypical group of novel emerging Brucella species. Clin Vaccine Immunol. 2012;19:1370-3.
25. Wu W, Zhang S, Qu J, Zhang Q, Li C, Li J, et al. Simultaneous detection of IgG antibodies associated with viral hemorrhagic fever by a multiplexed Luminex-based immunoassay. Virus Res. 2014.
26. Perry MB, Bundle DR. Antigenic relationships of the lipopolysaccharides of Escherichia hermannii strains with those of Escherichia coli O157:H7, Brucella melitensis, and Brucella abortus. Infect Immun. 1990;58:1391-5.
27. Caroff M, Bundle DR, Perry MB. Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9. Eur J Biochem. 1984;139:195-200.
28. Bundle DR, Gidney MA, Perry MB, Duncan JR, Cherwonogrodzky JW. Serological confirmation of Brucella abortus and Yersinia enterocolitica O:9 O-antigens by monoclonal antibodies. Infect Immun. 1984;46:389-93.
29. Perry MB, MacLean L, Griffith DW. Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7. Biochem Cell Biol. 1986;64:21-8.
30. Cloeckaert A, Tibor A, Zygmunt MS. Brucella outer membrane lipoproteins share antigenic determinants with bacteria of the family Rhizobiaceae. Clin Diagn Lab Immunol. 1999;6:627-9.
31. Doganay GD, Doganay M. Brucella as a potential agent of bioterrorism. Recent Pat Antiinfect Drug Discov. 2013;8:27-33.
32. Romero C, Lopez-Goni I. Improved method for purification of bacterial DNA from bovine milk for detection of Brucella spp. by PCR. Appl Environ Microbiol. 1999;65:3735-7.
33. Leal-Klevezas DS, Lopez-Merino A, Martmez-Soriano JP. Molecular detection of Brucella spp.: rapid identification of B. abortus biovar I using PCR. Arch Med Res. 1995;26:263-7.
34. Cloeckaert A, de Wergifosse P, Dubray G, Limet JN. Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay. Infect Immun. 1990;58:3980-7.
35. Bowden RA, Cloeckaert A, Zygmunt MS, Bernard S, Dubray G. Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry. Infect Immun. 1995;63:3945-52.
36. Kenne L, Unger P, Wehler T. Synthesis and nuclear magnetic resonance studies of some N-acylated methyl 4-amino-4,6-dideoxy-a-D-mannopyranosides. J Chem Soc Perkin. 1988;1:1183-6.
37. Peruski AH, Peruski LF. Immunological methods for detection and identification of infectious disease and biological warfare agents. Clin Diagn Lab Immunol. 2003;10:506-13.
38. Vanlalhmuaka, Thavachelvam K, Tuteja U, Sarika K, Nagendra S, Kumar S. Reverse line blot macroarray for simultaneous detection and characterization of four biological warfare agents. Indian J Microbiol. 2013;53:41-7.
39. Patra KP, Saito M, Atluri VL, Rolan HG, Young B, Kerrinnes T, et al. A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosis. PLoS Negl Trop Dis. 2014;8, e2926.
40. Meisel S, Stockel S, Elschner M, Melzer F, Rosch P, Popp J. Raman spectroscopy as a potential tool for detection of Brucella spp. in milk. Appl Environ Microbiol. 2012;78:5575-83.
41. Meikle PJ, Perry MB, Cherwonogrodzky JW, Bundle DR. Fine structure of A and M antigens from Brucella biovars. Infect Immun. 1989;57:2820-8.
42. Adone R, Muscillo M, La Rosa G, Francia M, Tarantino M. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18. PLoS One. 2011;6:e24073.
43. Wang Q, Shi X, Leymarie N, Madico G, Sharon J, Costello CE, et al. A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides. Biochemistry. 2011;50:10941-50.
44. Crich D, Vinogradova O. Synthesis of the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium. J Org Chem. 2007;72:6513-20.
45. Watson DC, Robbins JB, Szu SC. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect Immun. 1992;60:4679-86.
46. Skurnik M, Peippo A, Ervela E. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b. Mol Microbiol. 2000;37:316-30.
47. Velasco J, Moll H, Vinogradov EV, Moriyon I, Zahringer U. Determination of the O-specific polysaccharide structure in the lipopolysaccharide of Ochrobactrum anthropi LMG 3331. Carbohydr Res. 1996;287:123-6.
48. Burtnick MN, Brett PJ, Woods DE. Molecular and physical characterization of Burkholderia mallei O antigens. J Bacteriol. 2002;184:849-52.
49. Perry MB, MacLean LL, Schollaardt T, Bryan LE, Ho M. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun. 1995;63:3348-52.
50. Kenne L, Lindberg B, Unger P, Gustafsson B, Holme T. Structural studies of the Vibrio cholerae o-antigen. Carbohydr Res. 1982;100:341-9.